Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Knockdown of TMEM132A restrains the malignant phenotype of gastric cancer cells via inhibiting Wnt signaling.

Nucleosides, nucleotides & nucleic acids - 1 Jan 2023

Gao Qianqian, Chen Yufang, Yue Lingping, Li Ziyan, Wang Meihua

Abstract excerpt

Transmembrane protein 132 A (TMEM132A) has been recently reported to be a novel regulator of the Wnt signaling pathway, which is a cancer-associated cascade. However, the role of TMEM132A in cancer is not well characterized. Here, we used bioinformatics analysis to analyze the differential expression of TMEM132A in gastric cancer (GC) tissues and determine its diagnostic and prognostic value. Results showed that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Movement

Share to Cell Proliferation

Share to Epithelial-Mesenchymal Transition

Share to Gene Expression Regulation, Neoplastic

Share to Stomach Neoplasms

Share to Wnt Signaling Pathway

Source

Identifiers

PMID: 36441075
DOI: 10.1080/15257770.2022.2148692

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Knockdown of TMEM132A restrains the malignant phenotype of gastric cancer cells via inhibiting Wnt signaling.PMID 36441075Read ↗

PKMYT1 Promotes Gastric Cancer Cell Proliferation and Apoptosis ResistanceSemantic proximity Read ↗

Targeting Wnt Signaling for the Treatment of Gastric Cancer.Semantic proximity Read ↗

Identification of mini‐chromosome maintenance 8 as a potential prognostic marker and its effects on proliferation and apoptosis in gastric cancerSemantic proximity Read ↗

KIAA1324 Suppresses Gastric Cancer Progression by Inhibiting the Oncoprotein GRP78Semantic proximity Read ↗

Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progressionSemantic proximity Read ↗

A Novel Tumor Suppressor Gene, TMEM171, Inhibits the Development of Gastric Cancer by Dephosphorylating IKBα and Inactivating the NF-kB Signaling PathwaySemantic proximity Read ↗

TRIM 32 promotes cell proliferation and invasion by activating β‐catenin signalling in gastric cancerSemantic proximity Read ↗

Downregulated CMTM8 Correlates with Poor Prognosis in Gastric Cancer PatientsSemantic proximity Read ↗

MicroRNA-128 contributes to the progression of gastric carcinoma through GAREM-mediated MAPK signaling activation.Semantic proximity Read ↗

TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic targetSemantic proximity Read ↗

Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/β-catenin pathway.Semantic proximity Read ↗

Inhibited HDAC3 promotes microRNA-376c-3p to suppress malignant phenotypes of gastric cancer cells by reducing WNT2b.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.